CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Oct. 14, 2009--
AptarGroup, Inc. (NYSE:ATR) today reported third quarter results,
announced the completion of an acquisition in South America, and
declared a quarterly cash dividend of $.15 per share.
Third Quarter 2009 Summary
-
Consolidated sales decreased 11% from the prior year level and
decreased 7% excluding currency effects and acquisitions
-
Operating income reached $52.9 million despite challenging conditions,
a decline of 12% from the prior year, of which 4% was due to a charge
of $2.6 million for the previously announced facilities consolidation
and severance program
-
Certain regions and markets stabilized in the third quarter leading to
improved sales and profits over the second quarter
-
South American acquisition was completed
-
Strong balance sheet was maintained
THIRD QUARTER RESULTS
For the quarter ended September 30, 2009, sales decreased 11% to $473.7
million from $532.2 million a year ago. Product and custom tooling sales
declined 7%, changes in exchange rates accounted for 5% of the decline
and acquisitions added 1% to sales.
|
Third Quarter Segment Sales Analysis
|
|
(Change From Prior Year)
|
|
|
|
|
|
|
|
|
|
|
|
Beauty &
Home
|
|
Closures
|
|
Pharma
|
|
Total
AptarGroup
|
|
Product and Custom Tooling Sales
|
-7%
|
|
-9%
|
|
-3%
|
|
-7%
|
|
Currency Effects
|
-5%
|
|
-5%
|
|
-4%
|
|
-5%
|
|
Acquisitions
|
0%
|
|
2%
|
|
0%
|
|
1%
|
|
Reported Change in Sales
|
-12%
|
|
-12%
|
|
-7%
|
|
-11%
|
Commenting on the quarter, Peter Pfeiffer, President and CEO, said,
“Despite the continued difficult economic conditions, we have generally
preserved our operating margins through cost savings efforts and the
benefits of our diversified business model. Many of our customers
remained cautious in the quarter, but we believe inventory reductions
were reaching an end in certain markets and our third quarter results
improved sequentially over our second quarter results. Although it was
still a challenging quarter, we maintained our strong balance sheet.”
Pfeiffer added, “Our Beauty & Home segment sales declined 7%, excluding
currency effects, primarily due to continued weak demand from the
fragrance/cosmetic market in North America and Europe. This weakness was
partially offset by continued strong demand from South America and Asia,
and we benefited from improved demand in the personal care market.
Beauty & Home segment income declined 21% or $4.6 million in the quarter
primarily due to underutilized overhead and the negative impact of a
$1.2 million charge relating to severance expenses. Excluding the charge
for severance expenses, Beauty & Home segment income declined 16% or
$3.3 million.
Our Closures segment sales declined 9%, excluding currency effects and
acquisitions, due to the pass-through of resin cost decreases and weak
demand in Europe. We continued to see strong demand for our food and
beverage closures in North America and this offset some of the weakness
in Europe. Closures segment income decreased 15% or $1.8 million in the
quarter primarily due to the negative impact of a $1.4 million charge
relating to consolidation/severance expenses. Excluding the charge for
consolidation/severance expenses, Closures segment income declined 4% or
approximately $0.5 million.”
Pfeiffer continued, “Our Pharma segment reported stable performance in
the quarter. Sales declined by 3%, excluding currency effects, primarily
due to softer demand for our metered dose valves, but overall the
segment reported another strong operating result. Pharma segment income
declined 11% primarily due to lower sales and the impact of changes in
currency exchange rates.”
On a consolidated basis, operating income declined 12% to $52.9 million
(including approximately $2.6 million of consolidation/severance
expenses), down from $60.5 million a year ago.
Reported diluted earnings per share, which include the
consolidation/severance expenses, decreased 16% to $.48 per share.
Diluted earnings per share, excluding consolidation/severance expenses
of approximately $.03 per share, decreased 11% to $.51 compared to $.57
per share in the prior year.
YEAR-TO-DATE RESULTS
Year-to-date sales decreased 17% to approximately $1.3 billion from
approximately $1.6 billion a year ago. Product and custom tooling sales
declined 10%, changes in exchange rates accounted for 8% of the decrease
and acquisitions contributed 1% to sales.
Operating income decreased 23% to $141.5 million (including
approximately $5.7 million of consolidation/severance expenses), down
from $183.1 million a year ago. Reported diluted earnings per share,
which include the consolidation/severance expenses, decreased 26% to
$1.27 per share. Diluted earnings per share, excluding
consolidation/severance expenses of approximately $.05 per share,
decreased 23% to $1.32 compared to $1.72 per share in the prior year.
SOUTH AMERICAN ACQUISITION
In the quarter, AptarGroup acquired Covit do Brasil Componentes de
Alumínio para Perfumaria Ltda. (Covit do Brasil) for approximately $7.6
million. Covit do Brasil is a growing company that has been operating in
Brazil since 2005 developing and supplying anodized aluminum parts
primarily for the fragrance/cosmetic market. Covit do Brasil will
generally be supplying parts to other companies within AptarGroup.
Commenting on the acquisition, Pfeiffer said, “AptarGroup welcomes Covit
do Brasil’s stamping and anodizing capabilities to the group. While this
is a relatively small acquisition for us, their products and services
will reinforce our product offerings, help us better serve our
customers, and enhance our competitiveness in the fast growing South
American markets.”
OUTLOOK
Discussing the Company’s outlook, Pfeiffer stated, “The diversification
of our business has been a stabilizing factor in challenging times and
we expect that to continue. As we look to the fourth quarter, some of
our customers remain cautious going into the end of the year given the
continuing weak consumer sentiment and, consequently, our global
visibility remains limited at this time. However, we are cautiously
optimistic that inventories may be bottoming out in certain markets
though we expect the softness in the fragrance/cosmetic market to
continue in the near-term. We will continue to diligently manage our
costs without jeopardizing the flexibility necessary to respond to our
customers’ demands and we will maintain our strong balance sheet. When
comparing our fourth quarter results to the prior year, it is important
to note that declining resin costs in the fourth quarter of 2008 caused
a $5.2 million reduction in our LIFO inventory reserve. This positive
effect of approximately $.05 per diluted share is not expected to repeat
in the fourth quarter of 2009. Excluding facilities consolidation and
severance program charges, we anticipate diluted earnings per share for
the fourth quarter to be in the range of $.43 to $.48 per share compared
to $.46 per share in the prior year.”
CASH DIVIDEND AND SHARE REPURCHASE PROGRAM
The Board of Directors declared a quarterly dividend of $.15 per share,
payable November 18, 2009 to shareholders of record as of October 28,
2009.
During the quarter, the Company repurchased approximately 100,000 shares
of common stock for approximately $3.5 million leaving approximately 4.2
million shares authorized for repurchase at the end of the third quarter.
OPEN CONFERENCE CALL
There will be a conference call on Thursday, October 15, 2009 at 7:00
a.m. CDT to discuss the Company’s third quarter results for 2009. The
call will last approximately one hour. Interested parties are invited to
listen to a live webcast by visiting the Investor Relations page at www.aptargroup.com.
Replay of the conference call can also be accessed on the Investor
Relations page of the web site.
AptarGroup, Inc. is a leading global supplier of a broad range of
innovative dispensing systems for the fragrance/cosmetic, personal care,
pharmaceutical, household and food/beverage markets. AptarGroup is
headquartered in Crystal Lake, Illinois, with manufacturing facilities
in North America, Europe, Asia, and South America. For more information,
visit the AptarGroup web site at www.aptargroup.com.
This press release contains forward-looking statements. Forward-looking
statements are made pursuant to the safe harbor provisions of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934 and are based on management’s beliefs as well as
assumptions made by and information currently available to management.
Accordingly, AptarGroup’s actual results may differ materially from
those expressed or implied in such forward-looking statements due to
known or unknown risks and uncertainties that exist including, but not
limited to, economic, environmental or political conditions in the
various markets and countries in which AptarGroup operates, changes in
customer and/or consumer spending levels; financial conditions of
customers and suppliers; fluctuations in the cost of raw materials,
components and other input costs; the Company’s ability to increase
prices, contain costs and improve productivity; changes in capital
availability or cost, including interest rate fluctuations; the
competitive marketplace; fiscal and monetary policy; changes in foreign
currency exchange rates; direct or indirect consequences of acts of war
or terrorism; and labor relations. For additional information on
these and other risks and uncertainties, please see AptarGroup’s filings
with the Securities and Exchange Commission, including its Form 10-K’s
and Form 10-Q’s. Readers are cautioned not to place undue reliance on
forward-looking statements. AptarGroup undertakes no
obligation to update any forward-looking statements, whether as a result
of new information, future events or otherwise.
|
APTARGROUP, INC.
|
|
Condensed Consolidated Financial Statements (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
(In Thousands, Except Per Share Data)
|
|
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
September 30,
|
|
September 30,
|
|
|
2009
|
|
2008
|
|
2009
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
$ 473,668
|
|
|
$ 532,180
|
|
|
$ 1,345,992
|
|
|
$ 1,615,757
|
|
|
Cost of Sales (exclusive of depreciation
|
|
|
|
|
|
|
|
|
shown below)
|
320,675
|
|
|
366,637
|
|
|
899,222
|
|
|
1,102,325
|
|
|
Selling, Research & Development and
|
|
|
|
|
|
|
|
|
Administrative (1)
|
64,370
|
|
|
72,528
|
|
|
204,971
|
|
|
230,471
|
|
|
Depreciation and Other Amortization
|
33,054
|
|
|
32,537
|
|
|
94,590
|
|
|
99,864
|
|
|
Facilities Consolidation and Severance Expenses
|
2,631
|
|
|
-
|
|
|
5,726
|
|
|
-
|
|
|
Operating Income (2)
|
52,938
|
|
|
60,478
|
|
|
141,483
|
|
|
183,097
|
|
|
Other Income/(Expense):
|
|
|
|
|
|
|
|
|
Interest Expense
|
(3,965
|
)
|
|
(5,261
|
)
|
|
(12,569
|
)
|
|
(14,204
|
)
|
|
Interest Income
|
772
|
|
|
3,475
|
|
|
2,758
|
|
|
10,334
|
|
|
Equity in Results of Affiliates
|
-
|
|
|
194
|
|
|
-
|
|
|
417
|
|
|
Miscellaneous, net
|
(164
|
)
|
|
(635
|
)
|
|
(1,393
|
)
|
|
(1,320
|
)
|
|
Income before Income Taxes
|
49,581
|
|
|
58,251
|
|
|
130,279
|
|
|
178,324
|
|
|
Provision for Income Taxes (1)
|
16,114
|
|
|
18,557
|
|
|
41,746
|
|
|
56,475
|
|
|
Net Income
|
$ 33,467
|
|
|
$ 39,694
|
|
|
$ 88,533
|
|
|
$ 121,849
|
|
|
|
|
|
|
|
|
|
|
|
Net (Income)/Loss Attributable to Noncontrolling Interests
|
31
|
|
|
(43
|
)
|
|
90
|
|
|
(24
|
)
|
|
Net Income Attributable to AptarGroup, Inc.
|
$ 33,498
|
|
|
$ 39,651
|
|
|
$ 88,623
|
|
|
$ 121,825
|
|
|
Net Income Attributable to AptarGroup, Inc. Per Common Share:
|
|
|
|
|
|
|
|
|
Basic
|
$ 0.49
|
|
|
$ 0.59
|
|
|
$ 1.31
|
|
|
$ 1.79
|
|
|
Diluted
|
$ 0.48
|
|
|
$ 0.57
|
|
|
$ 1.27
|
|
|
$ 1.72
|
|
|
|
|
|
|
|
|
|
|
|
Average Numbers of Shares Outstanding:
|
|
|
|
|
|
|
|
|
Basic
|
67,691
|
|
|
67,670
|
|
|
67,691
|
|
|
67,958
|
|
|
Diluted
|
69,550
|
|
|
69,937
|
|
|
70,000
|
|
|
70,812
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Consolidated Statements of Income:
|
|
(1) In order to be comparable to the current period presentation,
the Company revised its 2008 presentation relating to a French
research and development tax credit by reclassifying amounts from
Provision for Income Taxes to Selling, Research & Development and
Administrative. For further details, refer to the Company's Form 8-K
that was filed with the Securities and Exchange Commission on July
17, 2009.
|
|
(2) Included in total Operating Income are expenses related to stock
options of approximately $1.6 million and $8.4 million in the third
quarter and first nine months, respectively, of 2009, and $1.3
million and $9.9 million in the third quarter and first nine months,
respectively, of 2008.
|
|
|
|
APTARGROUP, INC.
|
|
Condensed Consolidated Financial Statements (Unaudited)
|
|
(continued)
|
|
(In Thousands)
|
|
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
September 30, 2009
|
|
December 31, 2008
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
Cash and Equivalents
|
$ 294,851
|
|
$ 192,072
|
|
Receivables, net
|
325,392
|
|
343,937
|
|
Inventories
|
229,871
|
|
244,775
|
|
Other Current Assets
|
66,159
|
|
78,965
|
|
Total Current Assets
|
916,273
|
|
859,749
|
|
Net Property, Plant and Equipment
|
770,547
|
|
720,882
|
|
Goodwill, net
|
232,987
|
|
227,041
|
|
Other Assets
|
21,442
|
|
24,150
|
|
Total Assets
|
$ 1,941,249
|
|
$ 1,831,822
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
Short-Term Obligations
|
$ 90,461
|
|
$ 64,619
|
|
Accounts Payable and Accrued Liabilities
|
282,891
|
|
310,408
|
|
Total Current Liabilities
|
373,352
|
|
375,027
|
|
Long-Term Obligations
|
210,773
|
|
226,888
|
|
Deferred Liabilities
|
96,376
|
|
98,109
|
|
Total Liabilities
|
680,501
|
|
700,024
|
|
|
|
|
|
|
AptarGroup, Inc. Stockholders' Equity
|
1,260,021
|
|
1,131,030
|
|
Noncontrolling Interests in Subsidiaries
|
727
|
|
768
|
|
Total Equity
|
1,260,748
|
|
1,131,798
|
|
|
|
|
|
|
Total Liabilities and Equity
|
$ 1,941,249
|
|
$ 1,831,822
|
|
|
|
APTARGROUP, INC.
|
|
Condensed Consolidated Financial Statements (Unaudited)
|
|
(continued)
|
|
(In Thousands)
|
|
SEGMENT INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
September 30,
|
|
September 30,
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
2008
|
|
2009
|
|
2008
|
|
NET SALES
|
|
|
|
|
|
|
|
|
Beauty & Home
|
$ 239,621
|
|
|
$ 271,654
|
|
|
$ 665,234
|
|
|
$ 844,328
|
|
|
Closures
|
124,788
|
|
|
142,424
|
|
|
365,051
|
|
|
420,945
|
|
|
Pharma
|
109,258
|
|
|
118,102
|
|
|
315,705
|
|
|
350,479
|
|
|
Other
|
1
|
|
|
-
|
|
|
2
|
|
|
5
|
|
|
Total Net Sales
|
$ 473,668
|
|
|
$ 532,180
|
|
|
$ 1,345,992
|
|
|
$ 1,615,757
|
|
|
|
|
|
|
|
|
|
|
|
SEGMENT INCOME (1) (2)
|
|
|
|
|
|
|
|
|
Beauty & Home (3)
|
$ 16,815
|
|
|
$ 21,409
|
|
|
$ 38,769
|
|
|
$ 76,451
|
|
|
Closures (3)
|
10,443
|
|
|
12,280
|
|
|
35,800
|
|
|
35,597
|
|
|
Pharma (3)
|
31,269
|
|
|
35,077
|
|
|
91,752
|
|
|
101,171
|
|
|
Corporate Expenses and Other
|
(5,722
|
)
|
|
(8,772
|
)
|
|
(26,141
|
)
|
|
(31,049
|
)
|
|
Total Income Before Interest and Taxes
|
$ 52,805
|
|
|
$ 59,994
|
|
|
$ 140,180
|
|
|
$ 182,170
|
|
|
Interest Expense, Net
|
(3,193
|
)
|
|
(1,786
|
)
|
|
(9,811
|
)
|
|
(3,870
|
)
|
|
Net Income/(Loss) Attributable to Noncontrolling Interests
|
(31
|
)
|
|
43
|
|
|
(90
|
)
|
|
24
|
|
|
Income before Income Taxes
|
$ 49,581
|
|
|
$ 58,251
|
|
|
$ 130,279
|
|
|
$ 178,324
|
|
|
|
|
|
|
|
|
|
|
|
SEGMENT INCOME AS % OF NET SALES
|
|
|
|
|
|
|
|
|
Beauty & Home
|
7.0
|
%
|
|
7.9
|
%
|
|
5.8
|
%
|
|
9.1
|
%
|
|
Closures
|
8.4
|
%
|
|
8.6
|
%
|
|
9.8
|
%
|
|
8.5
|
%
|
|
Pharma
|
28.6
|
%
|
|
29.7
|
%
|
|
29.1
|
%
|
|
28.9
|
%
|
|
|
|
|
|
|
|
|
|
|
Notes to Segment Information:
|
|
|
|
|
|
|
|
|
(1) The Company evaluates performance of its business units and
allocates resources based upon income before interest expense net of
interest income, stock option and corporate expenses, income taxes
and certain unusual items.
|
|
|
|
(2) In order to be comparable to the current period presentation,
the Company revised its 2008 presentation relating to a French
research and development tax credit. For further details, see Note
(1) to Consolidated Statements of Income.
|
|
|
|
(3) Included in the segment income figures reported above, are
consolidation/severance expenses as follows:
|
|
CONSOLIDATION/SEVERANCE EXPENSES
|
|
|
|
|
|
|
|
|
Beauty & Home
|
$ 1,246
|
|
|
$ -
|
|
|
$ 1,503
|
|
|
$ -
|
|
|
Closures
|
1,385
|
|
|
-
|
|
|
4,223
|
|
|
-
|
|
|
Pharma
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Total Consolidation/Severance Expenses
|
$ 2,631
|
|
|
$ -
|
|
|
$ 5,726
|
|
|
$ -
|
|
Source: AptarGroup, Inc.
Stephen J. Hagge
AptarGroup, Inc.
815-477-0424
|
